CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.1.1.Top impacting factors
3.1.2.Top investment pockets
3.2.Key forces shaping veterinary CRO industry/ market
3.2.1.Bargaining power of buyers
3.2.2.Bargaining power of suppliers
3.2.3.Threat of new entrants
3.2.4.Threat of substitutes
3.2.5.Intensity of competitive rivalry
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Surge in ownership of companion animals
3.3.1.2.Rise in animal health expenditure
3.3.1.3.Increase in prevalence of diseases among companion animals
3.3.2.Restraint
3.3.2.1.Lack of standardization in veterinary CROs
3.3.3.Opportunity
3.3.3.1.Surge in awareness related to animal healthcare
3.3.4.Impact Analysis
3.4.COVID-19 Impact analysis on the market
CHAPTER 4:VETERINARY CRO MARKET, BY SERVICE TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Clinical trials
4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Toxicology
4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Market authorization and regulatory support
4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Others
4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
CHAPTER 5:VETERINARY CRO MARKET, BY ANIMAL TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Dogs
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Cats
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:VETERINARY CRO MARKET, BY INDICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Oncology
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Infectious disease
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Neurology
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
6.5.Others
6.5.1.Market size and forecast, by region
6.5.2.Market analysis, by country
CHAPTER 7:VETERINARY CRO MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America market size and forecast, by service type
7.2.3.North America market size and forecast, by animal type
7.2.4.North America market size and forecast, by indication
7.2.5.Market analysis by country
7.2.5.1.U.S.
7.2.5.1.1.U.S. market size and forecast, by service type
7.2.5.1.2.U.S. market size and forecast, by animal type
7.2.5.1.3.U.S. market size and forecast, by indication
7.2.5.2.Canada
7.2.5.2.1.Canada market size and forecast, by service type
7.2.5.2.2.Canada market size and forecast, by animal type
7.2.5.2.3.Canada market size and forecast, by indication
7.2.5.3.Mexico
7.2.5.3.1.Mexico market size and forecast, by service type
7.2.5.3.2.Mexico market size and forecast, by animal type
7.2.5.3.3.Mexico market size and forecast, by indication
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe market size and forecast, by service type
7.3.3.Europe market size and forecast, by animal type
7.3.4.Europe market size and forecast, by indication
7.3.5.Market analysis by country
7.3.5.1.Germany
7.3.5.1.1.Germany market size and forecast, by service type
7.3.5.1.2.Germany market size and forecast, by animal type
7.3.5.1.3.Germany market size and forecast, by indication
7.3.5.2.France
7.3.5.2.1.France market size and forecast, by service type
7.3.5.2.2.France market size and forecast, by animal type
7.3.5.2.3.France market size and forecast, by indication
7.3.5.3.UK
7.3.5.3.1.UK market size and forecast, by service type
7.3.5.3.2.UK market size and forecast, by animal type
7.3.5.3.3.UK market size and forecast, by indication
7.3.5.4.Italy
7.3.5.4.1.Italy market size and forecast, by service type
7.3.5.4.2.Italy market size and forecast, by animal type
7.3.5.4.3.Italy market size and forecast, by indication
7.3.5.5.Spain
7.3.5.5.1.Spain market size and forecast, by service type
7.3.5.5.2.Spain market size and forecast, by animal type
7.3.5.5.3.Spain market size and forecast, by indication
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe market size and forecast, by service type
7.3.5.6.2.Rest of Europe market size and forecast, by animal type
7.3.5.6.3.Rest of Europe market size and forecast, by indication
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by service type
7.4.3.Asia-Pacific market size and forecast, by animal type
7.4.4.Asia-Pacific market size and forecast, by indication
7.4.5.Market analysis by country
7.4.5.1.Japan
7.4.5.1.1.Japan market size and forecast, by service type
7.4.5.1.2.Japan market size and forecast, by animal type
7.4.5.1.3.Japan market size and forecast, by indication
7.4.5.2.China
7.4.5.2.1.China market size and forecast, by service type
7.4.5.2.2.China market size and forecast, by animal type
7.4.5.2.3.China market size and forecast, by indication
7.4.5.3.Australia
7.4.5.3.1.Australia market size and forecast, by service type
7.4.5.3.2.Australia market size and forecast, by animal type
7.4.5.3.3.Australia market size and forecast, by indication
7.4.5.4.Rest of Asia-Pacific
7.4.5.4.1.Rest of Asia-Pacific market size and forecast, by service type
7.4.5.4.2.Rest of Asia-Pacific market size and forecast, by animal type
7.4.5.4.3.Rest of Asia-Pacific market size and forecast, by indication
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by service type
7.5.3.LAMEA market size and forecast, by animal type
7.5.4.LAMEA market size and forecast, by indication
7.5.5.Market analysis by country
7.5.5.1.Brazil
7.5.5.1.1.Brazil market size and forecast, by service type
7.5.5.1.2.Brazil market size and forecast, by animal type
7.5.5.1.3.Brazil market size and forecast, by indication
7.5.5.2.South Africa
7.5.5.2.1.South Africa market size and forecast, by service type
7.5.5.2.2.South Africa market size and forecast, by animal type
7.5.5.2.3.South Africa market size and forecast, by indication
7.5.5.3.Saudi Arabia
7.5.5.3.1.Saudi Arabia market size and forecast, by service type
7.5.5.3.2.Saudi Arabia market size and forecast, by animal type
7.5.5.3.3.Saudi Arabia market size and forecast, by indication
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA market size and forecast, by service type
7.5.5.4.2.Rest of LAMEA market size and forecast, by animal type
7.5.5.4.3.Rest of LAMEA market size and forecast, by indication
CHAPTER 8:COMPETITIVE LANDSCAPE
8.1.Introduction
8.1.1.Market player positioning, 2019
8.2.Top winning strategies and key developments
8.3.Competitive dashboard
8.4.Competitive heatmap
CHAPTER 9:COMPANY PROFILES
9.1.CHARLES RIVER LABORATORIES, INC.
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Service portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.CLINVET
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Service portfolio
9.3.KLIFOVET AG
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Service portfolio
9.4.LoHLEIN & WOLF VET RESEARCH
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Service portfolio
9.5.ONCOVET CLINICAL RESEARCH
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Service portfolio
9.6.ONDAX SCIENTIFIC
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Service portfolio
9.7.TRIVERITAS
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Service portfolio
9.8.VETERINARY RESEARCH MANAGEMENT (VRM) LTD
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Service portfolio
9.9.VETPHARM, INC.
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Service portfolio
9.10.VETSPIN SRL
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Service portfolio